© Copyright 2025 American Medical Association. All rights reserved.
| Short Descr | ADM SARSCOV2 50 MCG/.5 ML 2ND | Medium Descr | IMM ADMN SARSCOV2 50 MCG/0.5 ML 2ND DOSE 6-11 | Long Descr | Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.5 mL dosage; second dose, when administered to individuals 6 through 11 years | Status Code | Not Valid for Medicare Purposes | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Non-Covered Service, not paid under OPPS | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2025-01-01 | Deleted | First appearance of code deletion in codebook. |
| 2024-01-01 | Added | First appearance in CPT Codebook |
| 2023-11-01 | Deleted | Code deleted. To report administration of COVID-19 vaccine, use 90480. |
| 2023-04-18 | Note | No longer authorized for use in the United States. |
| 2023-04-18 | Note | These codes used in the guidelines are no longer authorized for use in the United States: 0091A, 0093A, 0094A, 91301, 91306 91309, 91311. |
| 2023-04-18 | Note | Changes made to dosing information |
| 2022-12-08 | Note | AMA Guideline changed. 91316 received FDA approval. |
| 2022-11-16 | Note | AMA guideline changed to include 91316 effective upon receiving Emergency Use Authorization or approval from the FDA. |
| 2022-10-12 | Note | AMA Guideline changed. 91313 (12 yrs – 17 yrs) and 91314 both received FDA approval. |
| 2022-08-31 | Note | AMA guideline changed to include 91313, 91314 effective upon receiving Emergency Use Authorization or approval from the FDA. |
| 2022-08-31 | Note | AMA Guideline changed. 91313 (18 yrs & older) received FDA approval effective immediately. |
| 2022-08-31 | Note | Changes made to vaccine name, product & dosing information, & patient age (6-11). |
| 2022-06-17 | Added | Code published on AMA website 2022-07-06. Effective retroactively to 2022-06-17 |
| 2022-06-17 | Note | AMA guideline Includes 91311; Published on AMA website prior to addition of 0092A. Received FDA approval 2022-06-17. |
| 2022-06-17 | Note | AMA guideline includes 0091A, 0093A; Published to website 2021-07-06. Received FDA approval effective retroactively to 2022-06-17. |
| 2022-06-17 | Note | AMA guideline includes 0094A, 91301, 91306, 91309; published to website & received FDA approval prior to addition of 0092A. |